CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More →

CAR T Cell Detection: Anti-CAR Linker Antibodies for Whitlow/218 & G4S

CST® anti-CAR linker antibodies won The Innovation Award from CiteAb in 2023. Read on to learn why! ...
Amrik Singh, PhD Nov 8, 2022

Protect Your Project: Ensure You Can Get the Antibodies You Need to Keep Moving Forward

It seems that nearly every industry is still suffering from supply chain disruptions that began duri...
Craig Thompson Nov 3, 2022

A Day in the Life of a CST Product Scientist

It can seem like every week brings a new biotech innovation or another groundbreaking study that pro...
Gina Wasielewski Nov 2, 2022

Increase Your Experimental Success with CUT&RUN-Validated Antibodies

CUT&RUN delivers the power of chromatin immunoprecipitation (ChIP) or ChIP-sequencing (ChIP-seq)...
Christopher Fry, PhD Oct 26, 2022

Restoring a Living Shoreline: CST Volunteers with Salem Sound Coastwatch

Sustainability and giving back to the planet have always been an integral part of our DNA at Cell Si...
Anthony Michetti Oct 21, 2022

Comparing Antibody Concentrations & Performance; CST Antibody Details You May Not Know

When purchasing antibodies from Cell Signaling Technology (CST), you may notice that we typically re...
Josh Nathan Oct 12, 2022

M6A: A Cell’s Hidden Signal of Gene Regulation Through RNA

Guest author Gina Lee, PhD, is an Assistant Professor of Microbiology and Molecular Genetics at the ...
Gina Lee, PhD Sep 28, 2022

Therapeutic Approaches for the Treatment of Multiple Myeloma

Multiple myeloma is a cancer of plasma cells that is treatable, but not curable. In this blog, we re...
Andrea Tu, PhD Jul 2, 2022

Hypoxia and Its Role in Metabolism

Hypoxia—the deficiency of oxygen in the cellular environment—causes cellular stress and alters norma...
Chris Sumner Jun 8, 2022

It's All about the Affinity

In 2012 Roux et al. published in the Journal of Cell Biology a pioneering approach to identify the i...

Novel Therapeutic Approaches for Diffuse Large B-Cell Lymphoma

Lymphoma is a cancer of the lymphatic system, a principal part of the body’s immune system. Lymphoma...
Andrea Tu, PhD May 11, 2022

Pancreatic Cancer: Targeting Novel Drivers in the Tumor Microenvironment

Pancreatic cancer is devastating and difficult to diagnose early. The organ is located deep inside t...
Andrea Tu, PhD Apr 27, 2022

CST Becomes the First Life Science Company to Join 1% for the Planet

Long before our founder and CEO began producing antibodies for researchers around the globe, he was ...
Chris Sumner Apr 19, 2022

Which Fluorophores Can I Combine in My Flow Cytometry Experiment?

Flow cytometry offers the exciting ability to detect and quantify multiple readouts per cell, enabli...
Rob MacDonald, PhD Apr 13, 2022

Strategies for Successful Multiplex IF Experiments Using Conjugated Antibodies

One of the benefits of working with immunofluorescent (IF) analysis is the ability to compare multip...
Ginny Bain, PhD Apr 6, 2022

Melanoma: Aberrant Signaling Pathways and Therapeutic Approaches

There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melan...
Andrea Tu, PhD Mar 30, 2022

      Categories

      CST Newsletter

      Popular Posts

      Recent Posts
      blog-footer-landscape-blue-gradient

      About Us

       

      Help & Support

      Resources

      Legal

      For Research Use Only. Not for Use in Diagnostic Procedures.
      © 2025 Cell Signaling Technology, Inc. All Rights Reserved.